Investors

EastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr Lalit Upadhyay for Upcoming Initiatives

November 19, 2018 by admin

EastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives

Read more

CORRECTED LINK: CEO Anna Gluskin's interview with Uptick Newswire on 17 October 2018

October 22, 2018 by admin

Eastgate Biotech Corp. CEO Anna Gluskin's interview with Uptick Newswire on October 17, 2018

Read more

CEO Anna Gluskin, Interview with Uptick Network on October 17, 2018

October 22, 2018 by admin

Anna Gluskin's interview with Uptick Network on October 17, 2018

Read more

CEO Anna Gluskin's interview-Uptick network 17Oct2018

October 22, 2018 by admin

Anna Gluskin, CEO, Eastgate Biotech Corp. Interview on Uptick Network on 17Oct.2018

Read more

EastGate Biotech Signs Definitive Investment

August 27, 2018 by admin

EastGate Biotech Signs Definitive Investment and European Licensing Agreement With Nico Innovagroup S.r.l. for Liquid Insulin Mouth Rinse Solution Non-Dilutive Investment and Product License includes licensing fee and development costs

Read more

EastGate Biotech Provides Update on investment from Genluiching Mining Corporation

July 24, 2018 by admin

EastGate to receive the first non-dilutive investment tranch from the total funding up to $5 million USD as per the terms of the Definitive Agreement.

Read more

EastGate Biotech Expands Indications of Liquid Insulin Mouth Rinse Solution to Alzheimer’s Disease with Joint Venture Partner Genome Pharmaceuticals

June 28, 2018 by admin

Genome Pharma is the parent company of Netris/Origin BioPharmaceuticals the company’s Joint Venture Partner

Read more

EastGate Biotech Unveils Manufacturing Plans in an MOU with Mystic Pharmaceuticals Limited for its Liquid Insulin Mouth Rinse Solution

June 21, 2018 by admin

Focus on the manufacturing of the company’s liquid insulin mouth rinse solution for specific markets. Presently, EastGate is developing its insulin mouth rinse in the Philippines, Pakistan, and Europe through its JV with Nico Innovapharma.

Read more

Morphs into Global Licensing Play with $36 Million in Milestone Payments

June 20, 2018 by admin

Morphs into Global Licensing

Read more

EastGate Biotech Strikes Investment and Licensing Collaboration with Nico Innovapharma for Liquid Insulin Mouth Rinse Solution for the European Market

June 20, 2018 by admin

EastGate Biotech Strikes Investment and Licensing Collaboration with Nico Innovapharma for Liquid Insulin Mouth Rinse Solution for the European Market

Read more
RSS Icon